Investigating the Effects of IGFBP2 and IGF1 on Contextual Fear Extinction
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Aptinyx (United States), Northwestern University, Afraxis (United States), New York Medical College
Variable analysis
- Drug treatment (IGFBP2, IGF1, or sterile saline vehicle)
- Freezing behavior (quantified via FreezeFrame software during the last 3 minutes of each extinction trial)
- Shock chamber dimensions (40 × 40 × 40 cm)
- Shock intensity (0.5-mA 1-s footshocks)
- Shock delivery timepoints (90-, 210-, and 330-second timepoints)
- Extinction trial duration (5 minutes)
- Extinction trial frequency (daily for the first 6 days after training and on day 14 posttraining)
- Positive control: IGF1 (100 µg/kg i.v.)
- Negative control: Sterile saline vehicle (1 mL/kg i.v.)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!